Elucidating the exact pharmacological system of action (MOA) of naturally transpiring compounds can be demanding. Though Tarselli et al. (60) made the primary de novo synthetic pathway to conolidine and showcased this naturally transpiring compound correctly suppresses responses to both of those chemically induced and inflammation-derived pain, the